HOOK HOOKIPA Pharma, Inc. Net earnings per share growth forecast for next year
Patent battles in the immunology sector have triggered high volatility, as evidenced by the peak in next year's earnings per share (EPS) forecasts. HOOKIPA Pharma Inc. (HOOK) is currently integrating ESG standards and bioethics into its research. Secured IT platforms and contracts with industry behemoths guarantee stability. The metric stands at 40.30, while a sideways trend confirms the business's reliability without sharp declines.
Metric breakdowns and analytics for HOOKIPA Pharma (HOOK)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Debt to Equity HOOKIPA Pharma Inc.|HOOK - Long-Term Liabilities to Capital|Short-Term Debt to Equity HOOKIPA Pharma, Inc.|HOOK - Company Cumulative Debt|Debt to Book Capitalization Ratio HOOKIPA Pharma|HOOK - Company Long-Term Debts|Company Short-Term Debts HOOKIPA Pharma|Quick Liquidity hookipapharma.com
- earnings and valuation multiples information:
HOOK - Profit After Tax|Projected Future Earnings HOOKIPA Pharma Inc.|HOOK - P/E Multiple|Projected Price to Earnings HOOKIPA Pharma, Inc.|HOOK - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HOOKIPA Pharma|HOOK - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) HOOKIPA Pharma|HOOK - Earnings per share for the trailing year|Quarterly EPS earnings growth hookipapharma.com|HOOK - Earnings growth in current year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc.
- total revenue and sales volume data:
Fundamental company analysis:HOOK, HOOKIPA Pharma Inc.
Reliable express delivery air corridors for biocomponents minimize operational risks for HOOKIPA Pharma Inc. (HOOK), directly impacting the stability of future cash flows. This indicator aggregates expert consensus forecasts for changes in net earnings per share, reflecting the asset's fundamental attractiveness through the projected earnings per share dynamics for the coming year, which serves as a leading signal for assessing the company's growth potential.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year GRFS (Grifols Biemat)|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year celldex.com (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|Expected net earnings per share growth next year BioCryst Pharmaceuticals, Inc. BCRX|Net earnings per share growth forecast for next year Vera Pharma (VERA)|Earnings growth forecast for next year Dianthus Corp (DNTH)|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Consensus forecast of earnings per share growth for next year abcellera.com (ABCL)|TRML - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PGEN|PHAR: Earnings growth forecast for next year|Nektar Corp (NKTR) - Earnings growth forecast for next year|Expected earnings per share growth for next year UPB|ZBIO: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Immunome (IMNM)|GOSS: Net earnings per share change forecast for next year|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|Expected earnings per share trend next year SEPN|Pieris Pharmaceuticals - Earnings growth forecast for next year|SVRA - Earnings growth forecast for next year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth forecast for next year|AnaptysBio Inc - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Astria Pharma|Expected earnings per share growth for next year enGene Corp (ENGN)|Earnings growth forecast for next year RAPT|Earnings growth forecast for next year aerovatetx.com (JBIO)|Aclaris Therapeutics, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year KYTX|Tiziana Life Sciences PLC - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Cabaletta Bio Inc CABA|Ventyx Biosciences (VTYX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year THTX|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|Expected earnings per share growth for next year Eledon Pharmaceuticals Inc. (ELDN)|Expected earnings per share growth for next year AGEN (Agenus Inc)|Consensus forecast of earnings per share growth for next year Climb Bio, Inc|Earnings growth forecast for next year ZURA (Zura Bio Limited)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year ImageneBio Inc|shattucklabs.com (STTK) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Equillium (EQ)|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Earnings growth forecast for next year Immunic Inc|Net earnings per share growth forecast for next year Atara Biotherapeutics (ATRA)|IFRX: Net earnings per share change forecast for next year|Earnings growth forecast for next year XFOR (X4 Pharma)|Expected earnings per share trend next year ACET|Celularity Corp - Earnings growth forecast for next year|INMB - Earnings growth forecast for next year|Barinthus Biotherapeutics plc (BRNS) - Net earnings per share growth forecast for next year|Kezar Life Sciences Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year SAB Biotherapeutics, Inc|Expected earnings per share growth for next year Akari Therapeutics, Plc (AKTX)|Earnings growth forecast for next year ENLV|Earnings growth forecast for next year q32bio.com (QTTB)|GeoVax - Expected earnings per share growth for next year|Expected earnings per share trend next year EDSA|iBio Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Carisma Therapeutics CARM|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Bolt Biotherapeutics, Inc.|Net earnings per share growth forecast for next year HCW Biologics, Inc.|Expected earnings per share growth for next year Aptevo (APVO)|Expected earnings per share growth for next year AIM (AIM ImmunoTech)|Earnings growth forecast for next year aditxt.com (ADTX)|Net earnings per share growth forecast for next year GRI Bio, Inc. GRI|XRTX: Projected earnings per share growth rate for next year|Vyome Holdings - Earnings growth forecast for next year|Expected net earnings per share growth next year Revelation Biosciences Inc|INDP: Earnings growth forecast for next year|BiondVax Pharmaceuticals - Expected earnings per share trend next year|Net earnings per share growth forecast for next year CalciMedica Inc|Expected net earnings per share growth next year Affimed Therapeutics AFMD|Net earnings per share growth forecast for next year Allakos Inc. (ALLK)|IGMS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year iTeos ITOS|Earnings growth forecast for next year Ocean Biomedical Corp OCEA|TC Biopharm - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year thirdharmonicbio.com THRD
